I now have comprehensive content from Tintinalli's. Let me compile the full 20-mark short note.
Rapid-Sequence Intubation (RSI)
Based on Tintinalli's Emergency Medicine: A Comprehensive Study, 11th Edition
Definition
Rapid-sequence intubation (RSI) is the sequential administration of an induction (sedative) agent immediately followed by a neuromuscular blocking (paralytic) agent to facilitate endotracheal intubation. The goal is rapid insertion of the endotracheal tube (ETT) while minimizing physiologic perturbations, preventing aspiration, and optimizing intubating conditions.
Indications
RSI is the method of choice for emergency airway management. It is used when the patient requires immediate intubation and is not deeply comatose or in cardiorespiratory arrest (those may be intubated without pharmacologic assistance). Common clinical scenarios include:
- Airway protection in the unconscious or obtunded patient
- Respiratory failure (hypoxic or hypercapnic)
- Anticipated deterioration of airway (angioedema, burns, trauma)
- Status epilepticus requiring airway control
- Shock states where airway is compromised
RSI is superior to sedation alone and achieves the highest intubation success rate in properly selected emergency cases.
Relative Contraindications
- Anticipated difficult airway (anatomic abnormalities that muscle relaxation will not help)
- Clinical scenarios where relaxation will not improve laryngeal exposure (massive edema, immobile jaw, oral tumors/obstruction)
- Always have a rescue airway plan and equipment ready before initiating RSI
The RSI Steps (Table 29A-6, Tintinalli)
- Discuss airway management strategy with the team
- Set up IV access, cardiac monitor, pulse oximetry, capnography/capnometry
- Plan procedure - assess physiologic status and airway difficulty
- Prepare equipment, suction, and potential rescue devices
- Preoxygenate
- Consider pretreatment agents
- Give sedative agent immediately followed by neuromuscular blocking agent
- Intubate the trachea
- Confirm tube placement (capnography/colorimetric CO₂ detector)
- Secure the tube
- Adjust mechanical ventilation and provide post-intubation sedation
Preoxygenation
- Critical step to extend safe apnea time
- Goal: denitrogenate the lungs to create an oxygen reservoir (target SpO₂ ≥ 95%, ideally 100%)
- Methods: high-flow O₂ via non-rebreather mask (100% O₂ for 3 minutes of tidal breathing, or 8 vital-capacity breaths), or apneic oxygenation (high-flow nasal cannula at 15 L/min maintained throughout laryngoscopy)
- Avoid aggressive BVM ventilation prior to intubation to reduce aspiration risk
Pretreatment Agents (Table 29A-7, Tintinalli)
Administered 3-5 minutes before RSI to blunt the sympathetic response to laryngoscopy. Their use is optional as evidence of benefit is limited.
| Agent | Dose | Indications | Precautions |
|---|
| Lidocaine | 1.5 mg/kg IV | Elevated ICP, bronchospasm/asthma | Lack of evidence-based studies on ICP benefit |
| Fentanyl | 3 mcg/kg IV | Elevated ICP, cardiac ischemia, aortic dissection | Respiratory depression, hypotension, chest wall rigidity |
Sympathetic responses to laryngoscopy include rises in heart rate, blood pressure, and ICP - particularly important in TBI, hemorrhagic stroke, myocardial ischemia, or aortic dissection.
Induction (Sedative) Agents (Table 29A-8, Tintinalli)
There is no single agent of choice. Selection is based on clinical scenario.
| Agent | Dose | Onset | Duration | Key Points |
|---|
| Etomidate | 0.3 mg/kg IV | 15-45 sec | 5-15 min | Hemodynamically stable; protects myocardium and brain; causes myoclonus; single dose may suppress cortisol (clinical significance unclear); not an analgesic |
| Ketamine | 1-2 mg/kg IV | 45-60 sec | 10-20 min | Dissociative; provides analgesia + amnesia; bronchodilator (ideal in asthma/COPD); raises BP + HR via catecholamine release (good in shock/hypotension); does NOT increase ICP in sedated/ventilated patients; avoid in elderly and acute cardiac ischemia |
| Propofol | 1-2 mg/kg IV | 15-45 sec | 5-10 min | Anticonvulsant + antiemetic; lowers ICP; rapid onset and offset; causes hypotension via myocardial depression and vasodilation - avoid in trauma/shock |
| Midazolam | 0.1-0.3 mg/kg IV | 60-90 sec | 15-30 min | Used when other agents unavailable; less reliable depth and speed of onset |
Paralytic (Neuromuscular Blocking) Agents (Table 29A-9, Tintinalli)
Neuromuscular blockade eliminates protective airway reflexes and facilitates intubation. They provide NO analgesia or anxiolysis - concurrent sedation is mandatory.
Succinylcholine (Depolarizing Agent)
- Dose: 1.5 mg/kg IV (children <10 kg: 1.5-2 mg/kg; >10 kg: 1.0-1.5 mg/kg)
- Onset: ~45 seconds; Duration: 8-10 minutes (ultra-short acting)
- Mechanism: Depolarizing agent - high affinity for cholinergic receptors at motor end plate, resistant to acetylcholinesterase
- Advantages: Ultra-rapid onset; short duration (allows reassessment if intubation fails)
- Absolute contraindications: Hyperkalemia (risk of fatal cardiac arrest), denervation injury, crush injury >72 hrs, burns >72 hrs, prolonged immobility, rhabdomyolysis, undiagnosed neuromuscular disease (especially in children), personal/family history of malignant hyperthermia, open globe injury
- Other adverse effects: Fasciculations, increased intraocular/intragastric pressure, bradycardia (especially in children), increased ICP
Rocuronium (Non-Depolarizing Agent)
- Dose: 1-1.2 mg/kg IV (RSI dose)
- Onset: 45-60 seconds at RSI doses; Duration: 30-60 minutes
- Mechanism: Competes with acetylcholine at nicotinic receptors
- Advantages: No contraindication in hyperkalemia; preferred in children due to risk of undiagnosed neuromuscular disease with succinylcholine; preferred if succinylcholine contraindicated
- Reversal: Can be reversed with sugammadex (16 mg/kg for immediate reversal)
- In children: rocuronium has largely replaced succinylcholine as the paralytic of choice in pediatric emergency medicine
Special Clinical Scenarios
Traumatic Brain Injury (TBI)
- Goal: Prevent secondary brain injury
- Use fentanyl pretreatment to blunt ICP spike from laryngoscopy
- Ketamine is acceptable (does not elevate ICP in sedated/ventilated patients); may be cerebroprotective
- Avoid hypotension (worsens cerebral perfusion) - etomidate or ketamine preferred over propofol
- Avoid hypoxia and hypercarbia
Hypotensive/Shock Patient
- Ketamine is the agent of choice (maintains hemodynamics via catecholamine release)
- Etomidate is reasonable (minimal hemodynamic depression)
- Avoid propofol (causes significant hypotension)
- Use "Shock Dose" - reduce induction agent dose by 50% if profoundly hypotensive
Severe Asthma / Bronchospasm
- Ketamine is preferred (direct bronchodilator, smooth muscle relaxation)
- Lidocaine pretreatment may help prevent laryngospasm/bronchospasm
- Patients should be intubated sitting upright when possible
Elevated ICP
- Fentanyl pretreatment (3 mcg/kg IV) 3 min before RSI
- Etomidate or ketamine as induction agent
- Avoid hypotension post-intubation
Pediatric RSI
- RSI remains the preferred method in children in the ED
- Associated with highest success and lowest complication rates
- Atropine does NOT prevent succinylcholine-associated bradycardia in children and should NOT be given prophylactically
- Bradycardia in children is typically a sign of hypoxia - correct hypoxia first
- Rocuronium preferred over succinylcholine in children due to risk of hyperkalemic cardiac arrest in undiagnosed neuromuscular disease
- No evidence supports pretreatment agents in children
Airway Confirmation
After intubation, confirm ETT placement by:
- Waveform capnography (gold standard) - continuous end-tidal CO₂ monitoring
- Colorimetric end-tidal CO₂ detector (use adult device for children >15 kg)
- Bilateral breath sounds on auscultation
- Absence of epigastric sounds
- Chest X-ray (confirmatory, not primary)
- Direct visualization of ETT passing through vocal cords
Post-Intubation Management
- Secure the ETT immediately
- Adjust mechanical ventilation settings
- Provide post-intubation sedation and analgesia (mandatory, especially with longer-acting paralytics like rocuronium)
- Monitor for and manage complications (Table 29A-5, Tintinalli):
| Complication | Prevention | Management |
|---|
| ETT misplacement | View ETT through glottis | Remove and replace |
| Oxygen desaturation | Preoxygenate | Verify ETT; hyperventilate |
| Hypotension | Ensure BP adequate; avoid hypotensive agents | Trendelenburg; IV fluids; vasopressors; avoid hyperventilation |
| Aspiration | Avoid aggressive BVM; keep patient upright | Large-bore suction of oropharynx + ETT |
| Right mainstem intubation | Know appropriate ETT depth | Adjust ETT position |
| Cardiac arrest | Correct physiology before intubating | CPR |
Failed Airway / Rescue
Always anticipate and plan for failure:
- Have rescue airway devices ready (supraglottic airway: LMA, King tube)
- Surgical airway (cricothyrotomy) if "can't intubate, can't oxygenate"
- Sugammadex (16 mg/kg) can rapidly reverse rocuronium if intubation fails and spontaneous breathing must be restored
- Obesity, anatomic abnormalities, and difficult laryngoscopy are key risk factors - video laryngoscopy is the preferred primary device in many emergency departments
Prehospital RSI
- Critical care transport and ALS services perform RSI
- Raises the level of training, judgment, and psychomotor skills required
- Requires medical director oversight and ongoing quality assurance
- Smaller services with more intubation experience per provider (e.g., air medical) are better positioned to maintain RSI skills
- Carries risk of failed airway in setting of limited resources
Source: Tintinalli's Emergency Medicine: A Comprehensive Study, Chapters 29A and 113 (Pediatric section)